Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV Treatment Programs in Poor Countries as Effective as in Developed Countries

13.06.2005


Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.



Some have raised doubts that countries with extremely limited health care resources can effectively manage the complexities of antiretroviral therapy. But the new review of 10 medical studies on HIV treatment programs in the developing world showed that about 57 percent of patients had an undetectable level of HIV in their blood one year after starting ART, which is comparable to that in the developed world.

Availability and cost of ART medications are often barriers to treatment of HIV-infected people in countries lacking resources. Some countries, like Botswana, have government-funded ART programs that provide free or low-cost treatment to those in need. The article found that cost of medication was a significant factor--six months after ART initiation, nearly 30 percent more patients had undetectable viral levels when they received the drugs at no cost than did those who had to pay.


Lead author Louise Ivers, MD, of Harvard Medical School, was not surprised by the similarities in ART’s efficacy in poorer countries to that in industrial nations. "People in developing countries have just as much incentive to get well as in rich countries," she said, adding that, if ART is free, patients’ adherence to medication is good. However, "in most poor countries the cost of antiretrovirals is really prohibitive" and "even people who can afford it for a few months may not be able to afford it in the long term," said Dr. Ivers. "This shows that we have to try to find a way to provide free antiretrovirals." She hopes that the results showing a link between free ART and successful treatment of HIV will encourage governments in resource-limited countries to fund antiretroviral clinics for those in need.

All studies included in the review had to meet certain criteria, such as having only adult HIV patients, in order to effectively compare them with each other. Dr. Ivers, who works with HIV-infected patients in Haiti, believes the article’s findings would be the same regardless of how many studies were included. "We actually looked at hundreds of studies," Dr. Ivers said, but only selected "the ones that might meet the rich countries’ definition of antiretroviral success." However, many of the smaller studies not included "gave narrative descriptions of patients that had done well or gained weight" due to antiretroviral use.

An accompanying editorial by Carlos del Rio, MD, and Frances Priddy, MD, of Emory University, echoed Dr. Ivers’ sentiments and emphasized that "as substantial resources become available for treatment in resource-poor countries we must not allow funding for prevention to diminish."

Steve Baragona | EurekAlert!
Further information:
http://www.idsociety.org

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>